Definium Therapeutics, Inc.
DFTXNasdaqCIK 1813814HealthcareFiscal year ends Dec 31
Reports and events: 150 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1408:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-107275 |
| 2026-09-0808:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-384403 |
| 2026-08-1208:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-094528 |
| 2026-08-0616:16 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-338066 |
| 2026-08-0616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338006 |
| 2026-06-2417:14 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-077354 |
| 2026-06-2208:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-076091 |
| 2026-06-1216:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-269549 |
| 2026-05-1907:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-229657 |
| 2026-05-1208:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-218251 |
| 2026-05-0716:17 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-211989 |
| 2026-05-0716:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211929 |
| 2026-04-2716:05 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001193125-26-182034 |
| 2026-04-2216:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-170509 |
| 2026-02-2616:16 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-076742 |
| 2026-02-2616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076612 |
| 2026-01-2907:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-028186 |
| 2026-01-1208:24 ET | 8-K | 2.02 Results of operations; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-009854 |
| 2025-11-0616:18 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269596 |
| 2025-11-0616:12 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-269548 |
| 2025-10-3109:22 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-104696 |
| 2025-10-2916:11 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-103726 |
| 2025-09-0411:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-112973 |
| 2025-07-3116:20 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-100925 |
| 2025-07-3116:10 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-100902 |
| 2025-06-1617:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-086830 |
| 2025-05-2707:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-052719 |
| 2025-05-0807:25 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066387 |
| 2025-05-0807:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066374 |
| 2025-04-2316:15 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0001104659-25-038010 |
| 2025-04-2116:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-25-036841 |
| 2025-04-1507:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-053953 |
| 2025-03-0607:40 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-034176 |
| 2025-03-0607:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-034175 |
| 2025-01-3007:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-010802 |
| 2025-01-1308:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-002868 |
| 2024-12-1607:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-136386 |
| 2024-11-0716:25 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123391 |
| 2024-11-0716:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123366 |
| 2024-10-1716:18 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-109539 |
| 2024-08-1307:25 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-095753 |
| 2024-08-1307:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095749 |
| 2024-08-1208:38 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-088108 |
| 2024-06-2808:20 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-076037 |
| 2024-06-2008:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-075317 |
| 2024-06-1116:30 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-071953 |
| 2024-05-0816:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055681 |
| 2024-05-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055649 |
| 2024-04-2608:00 ET | DEF 14A | Proxy statementPeriod 2024-06-10 | 0001104659-24-052454 |
| 2024-04-0117:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-039484 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.